Company: CSTAF
Filing Date: 2025-04-02
Form Type: 10-K
Source: 0001213900-25-027555
Chunk: 1736

Company: Constellation Acquisition Corp I
Filing Date: 2025-04-02
Form: 10-K
Item: Item 9C
Chunk 1736
---
 7,664,302 Class A ordinary shares outstanding, of
which 64,302 Class A ordinary shares are held by the Company’s public shareholders.

On February 25, 2025, the Company drew an aggregate
of $5,000 (the “Extension Funds”), as approved by unanimous director resolution, dated February 25, 2024, pursuant to the
2024 Note (as defined below), which Extension Funds the Company deposited into the Company’s Trust Account for its public shareholders.
This deposit enables the Company to extend the date by which it must complete its initial business combination from February 28, 2025
to March 29, 2025 (the “First 2025 Extension”). The First 2025 Extension is the first of eleven one-month extensions permitted
under the Company’s amended and restated memorandum and articles of association and provides the Company with additional time to
complete its initial business combination. The note does not bear interest and matures upon closing of the Company’s initial business
combination. In the event that the Company does not consummate a business combination, the note will be repaid only from amounts remaining
outside of the Company’s Trust Account, if any.

On March 10, 2025, the
Company’s Class A ordinary shares started trading on the OTC Pink Market (“OTC Pink”) and the Company’s units
started trading on the OTCQB® Venture Market (“OTCQB”). The main difference between OTCQB and OTC Pink from OTCQX is that
securities listed on the OTCQB and OTC Pink undergo additional quality review and have different listing standards than those on the OTCQX,
although all are tiers of the OTC Markets. The trading symbols for the Class A ordinary shares and units remained the same.

The transition to OTC Pink
and OTCQB from OTCQX of the Company’s Class A ordinary shares and units is not expected to affect the Company’s business operations,
its relationships with partners or employees or its current SEC reporting obligations.

On March 27, 2025, the Company drew additional Extension Funds, as approved by unanimous resolution of the extension committee of the
Company’s board of directors, dated March 27, 2025, pursuant to the 2024 Note, which Extension Funds the Company deposited into
the Company’s Trust Account for its public shareholders. This deposit enables the Company to extend the date by which it must complete
its initial business combination from March